Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model.

Prostate cancer and prostatic diseases·2017
Same author

Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.

Current molecular medicine·2016
Same author

Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation.

Clinical pharmacology and therapeutics·2014
Same author

Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.

Prostate cancer and prostatic diseases·2012
Same author

C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells.

Diabetologia·2011
Same author

C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes.

Diabetologia·2009

Related Experiment Video

Updated: Jul 11, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Obesity, Diabetes and Cancer: A Mechanistic Perspective.

V Cifarelli1, S D Hursting2

  • 1Department of Medicine, Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA.

International Journal of Diabetology & Vascular Disease Research
|April 4, 2017
PubMed
Summary

Obesity and Type 2 diabetes increase cancer risk by promoting inflammation and altering growth factor signaling. Understanding these links may lead to new cancer prevention strategies using existing diabetes medications.

Keywords:
CancerDiabetesMetforminObesity

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

Area of Science:

  • Oncology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Obesity affects 35% of US adults and 20% of children, defined by BMI ≥ 30 kg/m².
  • Obesity is a significant risk factor for various cancers, often co-occurring with Type 2 diabetes mellitus and metabolic syndrome.
  • The obese and diabetic states create a pro-inflammatory microenvironment fostering crosstalk between immune, fat, and epithelial cells, thereby increasing cancer risk and progression.

Purpose of the Study:

  • To review the biological mechanisms linking obesity, diabetes, and cancer.
  • To emphasize the roles of growth factor signaling, inflammation, and vascular integrity in this association.
  • To identify potential therapeutic targets for cancer chemoprevention.

Main Methods:

  • Literature review synthesizing evidence on obesity-diabetes-cancer links.
  • Focus on key biological pathways.
  • Examination of potential drug repurposing for cancer prevention.

Main Results:

  • Obesity and diabetes promote cancer through enhanced growth factor signaling, inflammation, and altered vascular integrity.
  • Intercellular crosstalk in metabolic disease states contributes to cancer development.
  • Metformin and rosiglitazone are being investigated for cancer chemopreventive potential.

Conclusions:

  • The interplay between obesity, diabetes, and cancer involves critical biological pathways.
  • Targeting these pathways offers opportunities for cancer prevention.
  • Repurposing diabetes medications shows promise as a novel cancer chemoprevention strategy.